BioRestorative Therapies, Inc. (OTCMKTS:BRTX – Get Free Report) shares passed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $1.09 and traded as low as $0.2194. BioRestorative Therapies shares last traded at $0.2455, with a volume of 13,598,275 shares changing hands.
BioRestorative Therapies Trading Up 16.1%
The firm has a market capitalization of $2.53 million, a price-to-earnings ratio of -0.19 and a beta of 0.39. The stock’s 50-day moving average is $1.08 and its 200-day moving average is $1.33.
BioRestorative Therapies Company Profile
BioRestorative Therapies, Inc (OTCMKTS:BRTX) is a clinical-stage biotechnology company dedicated to developing regenerative medicine therapies for urological, orthopedic and rehabilitative indications. The company’s research focuses on autologous and allogeneic cell therapy platforms designed to repair, regenerate and restore normal tissue function through targeted cell delivery and expansion technologies.
Among its lead programs is BRTX-100, an investigational autologous muscle cell therapy aimed at treating stress urinary incontinence, which is advancing through late-stage clinical studies.
See Also
- Five stocks we like better than BioRestorative Therapies
- Think You Missed Silver? You’re Wrong. Here’s Why.
- The $5 vs. $800 Billion trade
- Your Bank Account Is No Longer Safe
- Trade this between 9:30 and 10:45 am EST
- Nvidia CEO Issues Bold Tesla Call
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
